CA2045593A1 - Use of 1,2-benzopyrone derivatives for the treatment of malignant tumours in humans - Google Patents

Use of 1,2-benzopyrone derivatives for the treatment of malignant tumours in humans

Info

Publication number
CA2045593A1
CA2045593A1 CA2045593A CA2045593A CA2045593A1 CA 2045593 A1 CA2045593 A1 CA 2045593A1 CA 2045593 A CA2045593 A CA 2045593A CA 2045593 A CA2045593 A CA 2045593A CA 2045593 A1 CA2045593 A1 CA 2045593A1
Authority
CA
Canada
Prior art keywords
treatment
humans
derivatives
malignant tumours
benzopyrone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2045593A
Other languages
French (fr)
Other versions
CA2045593C (en
Inventor
Kurt Zanker
R. Douglas Thornes
Helga Stolze
Ernest Marshall
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PRAEVOMED GESELLSCHAFT fur MEDIZINISCHE PRAVENTION MBH
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2045593A1 publication Critical patent/CA2045593A1/en
Application granted granted Critical
Publication of CA2045593C publication Critical patent/CA2045593C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/366Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37Coumarins, e.g. psoralen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • External Artificial Organs (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Monitoring And Testing Of Nuclear Reactors (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention relates to the use of 1,2-benzopyrone derivatives for the treatment of malignant tumors in human beings. The derivatives used according to the invention are suitable for both preventive and also therapeutic treatment and they display in particular growth-inhibiting effect vis-à-vis brain-tumor cells and cells from human renal, prostate, skin or lung carcinomas.
CA002045593A 1989-11-24 1990-11-23 Use of 1,2-benzopyrone derivatives for the treatment of malignant tumours in humans Expired - Lifetime CA2045593C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DEP3938902.2 1989-11-24
DE3938902A DE3938902C1 (en) 1989-11-24 1989-11-24
PCT/EP1990/002003 WO1991007959A1 (en) 1989-11-24 1990-11-23 Use of 1,2-benzopyrone derivatives for the treatment of malignant tumours in humans

Publications (2)

Publication Number Publication Date
CA2045593A1 true CA2045593A1 (en) 1991-05-25
CA2045593C CA2045593C (en) 2000-09-05

Family

ID=6394102

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002045593A Expired - Lifetime CA2045593C (en) 1989-11-24 1990-11-23 Use of 1,2-benzopyrone derivatives for the treatment of malignant tumours in humans

Country Status (11)

Country Link
EP (1) EP0455769B1 (en)
JP (1) JP3053645B2 (en)
KR (1) KR0177821B1 (en)
AT (1) ATE128354T1 (en)
AU (1) AU6739690A (en)
BR (1) BR9007080A (en)
CA (1) CA2045593C (en)
DE (2) DE3938902C1 (en)
DK (1) DK0455769T3 (en)
FI (1) FI913531A0 (en)
WO (1) WO1991007959A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2822379B1 (en) * 2001-03-20 2007-06-15 Sederma Sa COSMETIC AND DERMOPHARMACEUTICAL COMPOSITIONS CONTAINING UMBELLIFERONE
US7148252B2 (en) * 2001-10-03 2006-12-12 Signal Pharmaceuticals, Llc Use of benzopyranones for treating or preventing a primary brain cancer or a brain metastasis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5096887A (en) * 1984-03-01 1992-03-17 Lamorna Investments Proprietary Limited Treatment of high protein oedemas

Also Published As

Publication number Publication date
WO1991007959A1 (en) 1991-06-13
KR920700636A (en) 1992-08-10
DE59009724D1 (en) 1995-11-02
ATE128354T1 (en) 1995-10-15
DK0455769T3 (en) 1996-02-05
JP3053645B2 (en) 2000-06-19
CA2045593C (en) 2000-09-05
JPH04505020A (en) 1992-09-03
BR9007080A (en) 1991-12-24
EP0455769B1 (en) 1995-09-27
KR0177821B1 (en) 1999-03-20
EP0455769A1 (en) 1991-11-13
DE3938902C1 (en) 1991-05-08
AU6739690A (en) 1991-06-26
FI913531A0 (en) 1991-07-23

Similar Documents

Publication Publication Date Title
AU6800987A (en) Hyperthermic treatment of tumors
UA39158C2 (en) derivatives of N4-oxycarbonyl- 5'-deoxy-5-fluorocytidine and pharmaceutical preparation based thereon
BR9707125A (en) Compositions and processes for the treatment and diagnosis of breast cancer
CA2199117A1 (en) Compounds and methods for the treatment of cancer
FR2657259B1 (en)
IL110464A0 (en) Novel proteins for the diagnosis, imaging, and therapy of human cancer
AU4473596A (en) Methods of human prostate cancer diagnosis
EP0172721A3 (en) Use of phlorizin or its derivatives in the treatment of cancer
NO910340D0 (en) TOPICAL PREPARATIONS FOR TREATMENT OF HUMAN Nails.
PL323798A1 (en) Application of derivatives of vitamin d4 in treating skin diseases
WO1992002240A3 (en) Novel methods and compositions for treatment of angiogenic diseases
ZA982968B (en) Compositions and methods for the treatment and diagnosis of breast cancer
CA2214131A1 (en) Trisubstituted phenyl derivatives
AU1575697A (en) Compositions and methods for the treatment and diagnosis of cancer
AU581853B2 (en) Coumarin derivatives, pharmaceutical compositions containing the same, and the use thereof in the treatment of cancer
SE8404283D0 (en) APPLICATION OF A SPECIFIC TUMORALLY ASSOCIATED ANTIGEN, namely SIALOSYLLACTOTETRAUS, FOR DIAGNOSTIC AND THERAPEUTIC PROCEDURES FOR CANCER DISEASES
CA2045593A1 (en) Use of 1,2-benzopyrone derivatives for the treatment of malignant tumours in humans
NO953349L (en) Combination therapy of human cancer with cisplatin / tamoxifen
AU6617498A (en) Ascorbic acid as an adjuvant in the treatment of malignant tumors using chemo- and radiotherapy
AU3655097A (en) Brca1 compositions and methods for the diagnosis and treatment of breast cancer
ES2019713A6 (en) Treatment of malignant tumors with 8-chloroadenosine 3',5'-cyclic phosphate, 8-aminoadenosine 3',5'-cyclic phosphate and preparation thereof.
AU3255295A (en) Hybrid molecules useful in the treatment of tumors, their preparation and use in pharmaceutical compositions
ZA893310B (en) Novel strobilurine derivatives,their preparation and their use
AU1718292A (en) An inhibiting agent against the proliferation of malignant tumor cells of animals including human beings and its manufacture
CA2259997A1 (en) Remedies and preventives for stomatitis

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry